MiNK Therapeutics, Inc. (INKT)
11.91
-0.27
(-2.22%)
USD |
NASDAQ |
Dec 16, 16:00
12.20
+0.29
(+2.43%)
After-Hours: 19:17
MiNK Therapeutics Shareholders Equity (Quarterly): -13.51M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -274.14M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.96M |
| Total Liabilities (Quarterly) | 28.48M |
| Debt to Equity Ratio | -0.4237 |
| Current Ratio | 1.082 |
| Net Debt Paydown Yield | -0.41% |